CSI Market
Sign In | Register

Adc Therapeutics Sa (ADCT) Quarterly Income Statement

Quarterly · GAAP · USD millions
Access ADCT Annual Income Statement →
Income statement data covering Adc Therapeutics Sa–Jun 30 2025 offers a view into how Jun 30 2026's operating results have moved alongside business activity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
Q2 2026 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Revenues
Revenue From Contract With Customer Excluding Assessed Tax18.63
Total Revenue19.25
Costs & Expenses
Cost of Goods and Services Sold0.17
Gross Profit19.08
Selling, Administration, Marketing22.27
Depreciation & Amortization0.00
Research and Development Expense17.37
Restructuring, Settlement and Impairment Provisions2.67
Other operatinig exp. /-income2.18
Total operating costs including COS44.66
Operating income / -loss-25.41
Interest Expense0.00
Net Interest Expense / -Income0.00
Investment Income, Interest1.82
Income from affiliates-0.12
Other loss/ -income0.00
Total costs & expenses44.66
Income & Taxes
Income / -loss before income taxes-16.57
Income taxes expenses / -benefit0.00
Income after income taxes-16.57
Income / -loss from continuing operations-16.57
Net income / -loss-16.57
Income / -loss to shareholder-16.57
EBIT-16.57
EBITD-16.57
EBITDA-8.04
Earnings Per Share
Basic EPS (excl. extra items)-0.11
Basic Net EPS-0.11
Basic shares outstanding (Mill. of Units)155.02
Diluted Net EPS-0.11
Diluted average shares (Mill. of Units)155.02
4 historic quarters locked

Sign in to unlock the full Adc Therapeutics Sa income statement history.

Sign In Create Free Account

About Adc Therapeutics Sa Quarterly Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-Q filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-Q filings
  • Filed with the SEC: August 13, 2026
  • Original filing: adc-20260630.htm

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.